James L Gulley

81PUBLICATIONS
325CO-AUTHORS
Haematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Aug 06, 2026
Bi-directional support of T lymphoma and a lymphoma-associated monocyte population involving Notch signaling in mice.

|Jul 24, 2026
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

|Jul 01, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regression.

|Jun 08, 2026
GPR15-guided CD8+ T regulatory cells control intestinal inflammation.

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Mar 25, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.

Chennan Li, Ravi A Madan, Min-Jung Lee

Pageof 14

Frequent Collaborators

25 joint publications

Jeffrey Schlom

12 joint publications

Ravi A Madan

11 joint publications

Renee N Donahue

10 joint publications

Marijo Bilusic